Unlocking Insights: The real-world BrIDGE study on brodalumab effectiveness in psoriasis patients
Greece: A large-scale study evaluating brodalumab for moderate-to-severe plaque psoriasis revealed significant improvements in patient outcomes. The study of 638 patients showed that brodalumab led to substantial reductions in the Psoriasis Area and Severity Index (PASI) scores, with 74.0% achieving PASI ≤3 by week 12. In particular, 54.1% of patients achieved complete clearance (PGA0). The […]